TGA Approval

LORVIQUA lorlatinib 25 mg tablet blister pack (310778)

ARTG ID

310778

ARTG Name

LORVIQUA lorlatinib 25 mg tablet blister pack

Sponsor

Pfizer Australia Pty Ltd

ARTG Date

November 19, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

PFIZER AUSTRALIA PTY LTD

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-01987-1

http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-02264-1

Ingredient Name

lorlatinib

Empowering clinical research with data-driven insights and AI-powered tools.

LORVIQUA lorlatinib 25 mg tablet blister pack (310778) - TGA 批准文号 | MedPath